Contraceptive devices: subcutaneous delivery systems

Expert Review of Medical Devices
G BenagianoM Farris

Abstract

Ever since natural sex hormones have been identified, their structure defined and their synthesis achieved, it became clear that their circulating half-life was too short to allow use in therapy. One of the modalities most thoroughly investigated to prolong their duration of action is to embed them in a polymeric matrix and administer them subcutaneously. Research and development activities of devices to be inserted under the skin have focused upon two modalities: the first utilizes the so-called nonbiodegradable devices, in which the matrix is fixed and the drug is made available through diffusion. In the second, biodegradable devices, the matrix dissolves during the process and both the active compound and the matrix components reach the circulation. Although a number of biodegradable systems have been investigated in the form of polymeric rod or micropellets, so far no system has reached the marketplace. Several matrices have been evaluated: poly(ortho esters), (polylactic-polyglycolic acid)co-polymers, poly-(epsilon-caprolactone). In the case of nonbiodegradable systems, several have been in widespread use for years. The first such system, Norplant 1, consists of six capsules delivering levonorgestrel and lasts a minimum of...Continue Reading

References

Dec 10, 1976·Proceedings of the Royal Society of London. Series B, Containing Papers of a Biological Character·A Kessler, C C Standley
Sep 1, 1977·Journal of Toxicology and Environmental Health·J H Weikel, L W Nelson
Jul 1, 1979·Journal of Steroid Biochemistry·G Benagiano, H L Gabelnick
Oct 1, 1978·Contraception·E M Coutinho
Mar 1, 1976·Contraception·L C AndersonJ F Howes
Oct 1, 1991·Contraception·S DiazH B Croxatto
Jul 1, 1990·Contraception·S E OlssonE Johansson
May 1, 1990·Contraception·K Fotherby
May 1, 1989·American Journal of Obstetrics and Gynecology·P DarneyA Alvarado
Dec 1, 1969·American Journal of Obstetrics and Gynecology·H CroxattoP Atria
Jan 1, 1966·Endocrinology·P J Dziuk, B Cook
Jun 1, 1983·Drugs·G Benagiano, F M Primiero
Dec 1, 1981·Fertility and Sterility·E M CoutinhoI Sivin
Apr 29, 1998·Contraception·I S FraserI Sivin
Mar 30, 1999·Contraception·H B Croxatto, L Mäkäräinen
Jun 7, 2000·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·J HellerS Emmahl
Dec 8, 2000·Steroids·N KumarK Sundaram

Citations

Sep 23, 2008·Expert Review of Medical Devices·G BenagianoM Farris
Oct 1, 2011·Obesity Research & Clinical Practice·Hesham Abdul AzizYvonne Tze Fung Tan
Dec 3, 2015·Women's Health·G BenagianoIvo Brosens
Jun 21, 2016·Expert Opinion on Drug Delivery·Vuk Uskoković, Shreya Ghosh
Aug 9, 2016·Advanced Drug Delivery Reviews·Danir Fanisovich Bayramov, Jennifer Ann Neff
Jun 15, 2017·Drug Delivery and Translational Research·William R LykinsTejal A Desai
Oct 7, 2014·Journal of Materials Chemistry. B, Materials for Biology and Medicine·Abel SantosDusan Losic

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Hereditary Sensory Autonomic Neuropathy

Hereditary Sensory Autonomic Neuropathies are a group of inherited neurodegenerative disorders characterized clinically by loss of sensation and autonomic dysfunction. Here is the latest research on these neuropathies.

Spatio-Temporal Regulation of DNA Repair

DNA repair is a complex process regulated by several different classes of enzymes, including ligases, endonucleases, and polymerases. This feed focuses on the spatial and temporal regulation that accompanies DNA damage signaling and repair enzymes and processes.

Glut1 Deficiency

Glut1 deficiency, an autosomal dominant, genetic metabolic disorder associated with a deficiency of GLUT1, the protein that transports glucose across the blood brain barrier, is characterized by mental and motor developmental delays and infantile seizures. Follow the latest research on Glut1 deficiency with this feed.

Separation Anxiety

Separation anxiety is a type of anxiety disorder that involves excessive distress and anxiety with separation. This may include separation from places or people to which they have a strong emotional connection with. It often affects children more than adults. Here is the latest research on separation anxiety.

KIF1A Associated Neurological Disorder

KIF1A associated neurological disorder (KAND) is a rare neurodegenerative condition caused by mutations in the KIF1A gene. KAND may present with a wide range and severity of symptoms including stiff or weak leg muscles, low muscle tone, a lack of muscle coordination and balance, and intellectual disability. Find the latest research on KAND here.

Regulation of Vocal-Motor Plasticity

Dopaminergic projections to the basal ganglia and nucleus accumbens shape the learning and plasticity of motivated behaviors across species including the regulation of vocal-motor plasticity and performance in songbirds. Discover the latest research on the regulation of vocal-motor plasticity here.